Methods and compositions for immunomodulation
US7795242B2 · kind B2 · utility
11Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2004 |
| Grant date | Sep 14, 2010 |
| Priority date | — |
| Expiry date | May 24, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/343
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel antigens are provided herein. The antigens are associated with recognition of CD1 molecules by T cells. These antigens can be used as antigens, adjuvants or as immunomodulatory agents in a variety of therapeutic and prophylactic applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.